Cannabis Law Report

AUGUST 17, 2021

(Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

SpeedWeed

APRIL 2, 2021

The legacy of Charlotte Figi, the young Colorado girl whose struggle with epilepsy made CBD known worldwide, will be remembered next week with a benefit concert taking place in her honor. She had a rare form of epilepsy known as Dravet syndrome that caused dozens or even hundreds of seizures per day. A Benefit For Realm Of Caring.

Events 52

Events Epilepsy Cannabinoids Treatment 52

The Cannigma

MAY 19, 2021

Medical : Illegal Recreational : Illegal *CBD products are legal in Japan, as long as they contain no THC whatsoever and are not made from cannabis flower. Japan is known for its world-leading innovations, technology, and design, but when it comes to cannabis, the island nation remains decidedly regressive. But in modern times?

Law 137

Law Legalization Clinical Trials CBD 137

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. Doctors can prescribe Epidyolex – an oral solution of cannabidiol, which comes from the cannabis plant – if they think it will help sufferers. What is Epidyolex?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

MARCH 2, 2020

The global march toward cannabis legalization has seemingly awoken another long dormant area of scientific interest: psychedelics as medicine. Food and Drug Administration (FDA) granted Breakthrough Therapy designation (BTD) to Compass Pathways ‘ psilocybin therapy for treatment-resistant depression. In 2018, the U.S.

Medicine 59

Medicine Therapy DEA Pharmaceutical 59

The Joint Blog

FEBRUARY 15, 2020

According to a new study published in the journal Epilepsy & Behavior, abruptly stopping the use of CBD (cannabidiol) is not associated with physical withdrawal symptoms. Researchers reported no serious adverse events resulting from the discontinuation of CBD. weeks (Part 1) followed by 2?weeks weeks of 750?mg Conclusion.

CBD 54

CBD Treatment Events Epilepsy 54

MMJ Recs

APRIL 30, 2022

In some cases, there are events known as patient drives that can make the process even easier for qualifying individuals to get their recommendation and access medical marijuana. The certification process is same-day, meaning each patient can gain access to MMJ treatment the day of their appointment through the patient drive.

Patients 52

Patients Dispensary Chronic Pain Access 52

MMJ Recs

OCTOBER 2, 2023

California has been a trailblazer in the realm of medical marijuana, offering patients access to a variety of treatment options. If the doctor determines that medical cannabis is a suitable treatment option, they will provide a recommendation for the patient.

Dispensary 52

Dispensary Patients Environment Conditions 52

The Joint Blog

JANUARY 10, 2022

CBD (cannabidiol) forms part of over 100 chemical components called cannabinoids discovered in the cannabis plant, Cannabis sativa. The psychoactive cannabinoid known as tetrahydrocannabinol (THC) is the most famous cannabinoid found in cannabis, which means it causes a high feeling. Symptoms include: Reliving traumatic events.

CBD 41

CBD Sleep Treatment Epilepsy 41

Otherside Farms

JANUARY 17, 2020

The newest food trend around the globe is an increase in beverages and foods containing cannabidiol, the chemical compound found in cannabis plants. The Food and Drug Administration allows the use of CBD to treat pain, anxiety, depression, nausea, and some types of epilepsy. So, how does cannabis affect eating lifestyles?

Food 52

Food Research and Development Seed-To-Sale Vaping 52

PrestoDoctor

JUNE 2, 2020

Forecasts state that the medical marijuana market will be worth more than $8 billion by 2024, and the global medical cannabis market is predicted to reach a net worth of $73.6 Even in this event, you might still want to see a medical marijuana doctor. Informing Yourself on the Benefits of Medical Cannabis. billion by 2027.

Marijuana 52

Marijuana Epilepsy Conditions Chronic Pain 52

CannaMD

SEPTEMBER 15, 2020

SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. Patients suffering from cancer, epilepsy, chronic seizures, or muscle spasms could use low-THC cannabis products recommended by a licensed doctor. Qualified patient.

Law 126

Law Marijuana Patients Treatment 126

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Patients using warfarin need to have their blood INR level tested after adding THC-containing cannabis to their regimen. CBD and Glaucoma. Does CBD also help?

CBD 98

CBD THC Conditions Medicine 98

Otherside Farms

APRIL 26, 2021

Read on to learn more about how the consumption of Plain Jane cannabis-derived products affects the brain. Unlike other cannabinoids found in hemp and cannabis , cannabidiol interacts only mildly with CB1 and CB2 receptors. Additionally, such products can also help treat neuropsychiatric disorders and epilepsy.

Consumption 52

Consumption CBD Extraction Chronic Pain 52

Cannabis Law Report

NOVEMBER 5, 2019

You might feel anxious before a meeting, an examination, or a big event. CBD is a type of cannabinoid that occurs naturally in cannabis plants. The first thing to note on this subject matter is there is isn’t a large body of research on anxiety treatment using CBD oil. Anxiety is a daily occurrence for most of us. What Is CBD.

Oil 58

Oil CBD Digestion Epilepsy 58

Kind Meds (Cannabis Education Blog)

AUGUST 16, 2021

Does Cannabis Help With Running or Training? It doesn’t give a huge boost to one’s muscles like steroids or allow your blood to carry more oxygen like PEO, and an epileptic who treats their seizures with a cannabinoid tincture is only made less susceptible to seizures during events and training.

Marijuana 111

Marijuana Chronic Pain Tincture Cannabinoids 111

MMJ Recs

MARCH 25, 2022

In the state of New York, an MMJ card also allows you to grow a limited amount of medical cannabis yourself. Patient drives are like pop-up day events, during which many people can avail of quick and easy appointments for MMJ cards if they have a qualifying condition. MMJ is proven to help with numerous medical conditions.

Patients 52

Patients Conditions Chronic Pain Dispensary 52

Cannabis Law Report

JANUARY 13, 2020

Advance the medical literature regarding Epidiolex through publications in top-tier medical journals and at major scientific and medical meetings, notably the American Academy of Neurology and American Epilepsy Society meetings. Additional pipeline: Commence Phase 2b study of a cannabidiol formulation for the treatment of schizophrenia.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

MMJ Recs

MARCH 2, 2024

What to Expect at Ohio Medical Cannabis Dispensaries In Ohio medical cannabis dispensaries, patients can anticipate a welcoming and professional environment focused on holistic wellness. While browsing, you’ll encounter a diverse range of cannabis products, including flower, edibles, tinctures, and more.

Dispensary 52

Dispensary Patients Marijuana Education 52

Canna Law Blog

MAY 29, 2019

Department of Homeland Security that has authority over the security of the traveling public in the United States, maintained the position that: Possession of marijuana and cannabis infused products, such as Cannabidoil (CBD) oil, is illegal under federal law. Alcohol and Tobacco and Trade Bureau , the U.S.

Hemp 78

Hemp CBD Agriculture Policy 78

Cannabis Law Report

AUGUST 24, 2021

. “Nearly 100,000 people in the United States have idiopathic pulmonary fibrosis (IPF), and although cases continue to climb, there is still a significant unmet need in treatment options for this chronic disease,” said Chris Chapman, M.D., President, Director and Chief Medical Officer. Investor Contact: Robert Schatz. 646) 421-9523.

Pharmaceutical 98

Pharmaceutical Clinical Trials Chronic Pain CBD 98

The Joint Blog

MARCH 9, 2022

A pre-roll is an all-set joint loaded up with cannabis that you can purchase from a store-it’s pre-rolled for you. Pre-roll has turned into the business favored term, rather than “joint,” however numerous cannabis buyers call them joints. Properties of Pre-rolls That Can Help With Mental Issues:-.

Sleep 26

Sleep Treatment Conditions Epilepsy 26

LifeCannMD

DECEMBER 13, 2021

On January 3, 2017, Amendment 2 came into effect in Florida allowing for the legal medicinal use of cannabis.The rules for use and administration are outlined in Senate Bill 8A of The Florida Medical Marijuana Legalization Initiative which allows for treatment of “diagnosable, debilitating conditions.” Learn more here. Learn more here.

Conditions 52

Conditions Chronic Pain Marijuana Patients 52

Cannabis Law Report

DECEMBER 1, 2021

Because it can cross the blood-brain barrier and gain access to the central nervous system (CNS), MYMD-1 is also positioned to be a possible treatment for brain-related disorders. The Company believes that Supera-CBD is currently on a path toward human clinical trials as a therapy for epilepsy, followed by chronic pain. Robert Schatz.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Therapy 52

Cannabis Law Report

JUNE 1, 2021

Director of Medical Affairs and a Product Development Team lead at Greenwich Biosciences, where he played an important role in the complex, successful commercialization of the first cannabis-based product approved by the FDA to treat rare forms of epilepsy. CAMBRIDGE, Mass.–(BUSINESS Sesen Bio, Inc.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Cannabis Law Report

MAY 19, 2022

While this is the first time that FDA has ever issued Warning Letters for products containing delta-8 THC, we view this set of Warning Letters to signify FDA’s continuing enforcement of federal restrictions on the marketing and sale of products containing cannabis-derived ingredients. CBD oil is an effective natural treatment for OCD.”. “If

THC 52

THC CBD Food Pets 52

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. Patients using warfarin need to have their blood INR level tested after adding THC-containing cannabis to their regimen. How Do CBD Drug Interactions Occur? CBD and Glaucoma.

CBD 52

CBD THC Conditions Medicine 52

Cannabis Law Report

JANUARY 5, 2022

The issued claims protect the use of MYMD-1 in a method of treatment for the progressive and generalized loss of skeletal muscle mass and strength known as sarcopenia. MYMD-1 also shows promise in pre-clinical studies as a potential treatment for post- COVID-19 complications and as an anti-fibrotic and anti-proliferation therapeutic.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

Cannabis Law Report

OCTOBER 19, 2021

MYMD-1’s primary purpose is to slow the aging process and extend healthy lifespan, and it is also showing promise as a potential treatment for post- COVID-19 complications and as an anti-fibrotic and anti-prolific therapeutic. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy.

Pharmaceutical 52

Pharmaceutical Therapy Clinical Trials Chronic Pain 52

Cannabis Law Report

NOVEMBER 23, 2021

It’s also important to note that MYMD-1 shows promise in pre-clinical studies as a treatment for immune diseases including rheumatoid arthritis, multiple sclerosis, and Hashimoto’s thyroiditis, and as an anti-fibrotic and anti-proliferation therapeutic.”. MyMD Contact: Robert Schatz. 646) 421-9523. rschatz@mymd.com www.mymd.com.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Chronic Pain 52

Cannabis Law Report

SEPTEMBER 20, 2021

cannabis industry, announced that it closed on the acquisition of a property in Missouri, and entered into a long-term lease with CPC of Missouri – Smithville, LLC (CPC), a subsidiary of Calyx Peak, Inc. CPC intends to operate the property upon completion of construction as a licensed cannabis cultivation and processing facility.

Cultivation 52

Cultivation Dispensary Patients Epilepsy 52

Cannabis Law Report

NOVEMBER 16, 2021

Our treatment designed for delaying aging has a distinctive drug profile of oral delivery, selectivity, and very low toxicity as compared with TNF blockers, all of which are delivered by injection only. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy. 646) 421-9523.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

JANUARY 20, 2022

Eleusis designed ELE-Psilo, a proprietary psilocybin-based drug candidate that is formulated for IV infusion and in development for the treatment of depression. Eleusis secured an Innovation Passport Designation for ELE-Psilo in adult treatment-resistant depression under the U.K. II is a $287.5

Therapy 52

Therapy Research and Development Business Access 52

Cannabis Law Report

SEPTEMBER 13, 2021

MYMD-1’s primary purpose is to slow the aging process and extend human lifespan, but it is also showing promise as a potential treatment for COVID-19-related complications, and as an anti-fibrotic and anti-prolific therapeutic. The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy.

Clinical Trials 52

Clinical Trials Pharmaceutical Research and Development Therapy 52

Veriheal

OCTOBER 5, 2020

Hawaii legalized cannabis in its’ House Bill 2729 which was passed in 2018. Previously to now, the bill did not allow for the sale of cannabis edibles but as of the 1st of January 2021, the citizens of Hawaii will be able to purchase edibles from licensed medical cannabis dispensaries. . What are Cannabis Edibles?

Edibles 52

Edibles Legalization Decriminalization Consumption 52

Puff Puff Post

NOVEMBER 30, 2018

But there are no cannabis laws for pets in Canada. With Canada legalizing cannabis, we are now seeing a growing interest in using CBD oil for pets. The cannabis plant contains hundreds of cannabinoids. SEE RELATED ARTICLE Pot for Pets: Can Cannabis Treat Animals? All these may change soon. file image).

Pets 76

Pets Oil CBD Research and Development 76

Project CBD

FEBRUARY 28, 2023

The combined total from both channels — $58,293,034 — does not include CBD sales in licensed cannabis dispensaries or CBD products, such as vapes, tinctures, gummies, and other edibles sold online. (E-commerce According to the FDA, “hemp” is defined as Cannabis sativa with a tetrahydrocannabinol (THC) concentration of 0.3%

CBD 144

CBD Seed-To-Sale Food Access 144